Skip to main content

Table 2 Values of the carotid intima media thickness (IMT) of the patients < 40 years and ≥ 40 years

From: Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study

Variables

< 40 y group

≥ 40 y group

Carotid MIT Median (P25; P75)

p-value

Carotid MIT Median (P25; P75)

p-value

HAART use

 

p = 0.069

 

p = 0.166

Yes

0.735 (0.691; 0.792)

 

0.840 (0.772; 0.917)

 

No

0,722 (0.677; 0.780)

 

0.827 (0.740; 0.915)

 

CD4 T-lymphocytes (cells/mm3)

 

p = 0.373

 

p = 0.011

<200

0.720 (0.685; 0.782)

 

0.797 (0.742; 0.964)

 

200 to 350

0.728 (0.681; 0.792)

 

0.822 (0.760; 0.919)

 

≥ 350

0.731 (0.693; 0.779)

 

0.852 (0.802; 0.920)

 

Viral load (copies/mL)

 

p = 0.269

 

p = 0.616

< 50

0.745 (0.677; 0.822)

 

0.836 (0.765; 0.135)

 

50 to < 10.000

0.742 (0.705; 0.795)

 

0.837 (0.757; 0.940)

 

10.000 to < 100.000

0.723 (0.681; 0.769)

 

0.852 (0.763; 0.922)

 

≥ 100,000

0.690 (0.682; 0.741)

 

0.831 (0.775; 0.918)

 

Types HAART regimens

 

p = 0.109

 

p = 0.132

No HAART use

0.722 (0.677; 0.780)

 

0.827 (0.740; 0.915)

 

PI

0.733 (0.690; 0.767)

 

0.782 (0.732; 0.875)

 

NNRTI

0.729 (0.696; 0.784)

 

0.837 (0.778; 0.897)

 

Duration of use of HAART

 

p = 0,015

 

p = 0.070

No use

0.722 (0.677; 0.780)

 

0.827 (0.740; 0.915)

 

< 5 years

0.730 (0.690; 0.790)

 

0.830 (0.757; 0.918)

 

≥5 years

0.757 (0.730; 0.815)

 

0.864 (0.805; 0.915)